In the pharmaceutical and biotechnology industries, producing safe, sterile medications (such as vaccines, biologics, or cell therapies) requires absolute environmental control. Governing bodies like the FDA and EMA enforce strict cGMP (Current Good Manufacturing Practice) regulations to ensure product safety.
In a pharmaceutical cleanroom, the Fan Filter Unit (FFU) is the primary mechanism for maintaining the sterile envelope. However, not just any commercial fan will pass a regulatory audit.
As a trusted manufacturer of life science cleanroom equipment, Wujiang Deshengxin (DSX) Purification engineers FFUs specifically designed to support and simplify your cGMP compliance process. Here is how our technology aligns with critical regulatory requirements.
According to EU GMP Annex 1 and FDA guidelines, critical aseptic processing areas (Grade A / ISO Class 5) must utilize unidirectional airflow to sweep contaminants away from the exposed product.
The cGMP Requirement: The airflow velocity must be continuously maintained at 0.45 m/s (±20%) at the working position, without turbulence or "dead zones" where microbes can settle.
The DSX Solution: We utilize proprietary EC (Electronically Commutated) Motors with Constant Airflow Technology. As the HEPA filter naturally loads with particulate over time, the DSX smart controller automatically adjusts the motor torque to maintain a steady, compliant 0.45 m/s velocity. Our custom aerodynamic diffusers ensure this air exits the FFU evenly, providing a flawless, unidirectional sterile shield.
cGMP guidelines mandate routine leak testing of installed HEPA filters to ensure zero bypass of contaminated air.
The cGMP Challenge: Traditional FFUs require technicians to breach the ceiling plenum to inject the test aerosol, which risks contaminating the cleanroom and causes massive production downtime.
The DSX Solution: We manufacture Room-Side Replaceable (RSR) FFUs. These specialized units feature built-in aerosol injection and sampling ports directly on the room-side face. Validation technicians can perform mandatory PAO (Polyalphaolefin) integrity testing from inside the cleanroom quickly and safely, drastically reducing downtime while satisfying auditor requirements.
In a biological cleanroom, any microscopic gap is a potential breeding ground for bacteria or mold.
The cGMP Requirement: Equipment must be designed for easy cleaning, sanitization, and must guarantee no unfiltered air can bypass the filter media.
The DSX Solution: Instead of relying on mechanical neoprene gaskets that degrade over time, DSX pharmaceutical FFUs utilize Gel-Seal Technology. A knife-edge flange on the FFU housing penetrates a track of non-Newtonian fluid gel on the HEPA filter, creating a flawless, self-healing airtight barrier. Furthermore, our fully welded SS304/SS316L stainless steel housings eliminate hidden crevices, making them highly resistant to Vaporized Hydrogen Peroxide (VHP) sterilization cycles.
Modern cGMP compliance is heavily reliant on data. Auditors want proof that the cleanroom maintained positive pressure and correct airflow continuously during production (e.g., 21 CFR Part 11 compliance).
The cGMP Requirement: Facility managers must monitor, record, and verify environmental conditions.
The DSX Solution: DSX Smart FFUs integrate seamlessly into your central Building Management System (BMS) via Modbus RTU or TCP/IP. Our software provides real-time monitoring of motor RPM, power consumption, and fault alarms. It logs historical performance data, providing QA managers with the exact traceability needed to prove continuous compliance during an FDA or EMA audit.
Achieving cGMP compliance shouldn't be a struggle against inadequate equipment. By partnering with DSX Purification, you integrate compliance directly into your facility's infrastructure.
From full IQ/OQ/PQ validation support to VHP-resistant hardware, we manufacture the certainty that pharmaceutical giants rely on.
[ Request Specs for VHP-Resistant & Gel-Seal Pharmaceutical FFUs ]